Research on correlations of miR-585 expression with progression and prognosis of triple-negative breast cancer
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Research on correlations of miR-585 expression with progression and prognosis of triple-negative breast cancer
Authors
Keywords
-
Journal
CLINICAL AND EXPERIMENTAL MEDICINE
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-04-07
DOI
10.1007/s10238-021-00704-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MCT-1/miR-34a/IL-6/IL-6R signaling axis promotes EMT progression, cancer stemness and M2 macrophage polarization in triple-negative breast cancer
- (2019) Yueh-Shan Weng et al. Molecular Cancer
- MiR-140-5p inhibits cell proliferation and metastasis by regulating MUC1 via BCL2A1/MAPK pathway in triple negative breast cancer
- (2019) Bofan Yu et al. CELL CYCLE
- The therapeutic potential of miR-7 in cancers
- (2019) Miao Li et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Downregulated miR-585-3p promotes cell growth and proliferation in colon cancer by upregulating PSME3
- (2019) Chunmei Liu et al. OncoTargets and Therapy
- Functions and mechanisms of miR-186 in human cancer
- (2019) Zhen Wang et al. BIOMEDICINE & PHARMACOTHERAPY
- MiR-210 Is Overexpressed in Tumor-infiltrating Plasma Cells in Triple-negative Breast Cancer
- (2019) Isabelle Bar et al. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
- Recent treatment progress of triple negative breast cancer
- (2019) Yang Chang-Qing et al. PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY
- Upregulation Of miR-153 Inhibits Triple-Negative Breast Cancer Progression By Targeting ZEB2-Mediated EMT And Contributes To Better Prognosis
- (2019) Dongliang Shi et al. OncoTargets and Therapy
- MicroRNA-585 suppresses tumor proliferation and migration in gastric cancer by directly targeting MAPK1
- (2018) Lei Hu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Epigenetic regulation of miR-200 as the potential strategy for the therapy against triple-negative breast cancer
- (2018) Janaki Ramaiah Mekala et al. GENE
- MicroRNAs in regulation of triple-negative breast cancer progression
- (2018) Dominika Piasecka et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Long non-coding RNA (LncRNA) RMST in triple-negative breast cancer (TNBC): Expression analysis and biological roles research
- (2018) Li Wang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- MiR-25-3p promotes the proliferation of triple negative breast cancer by targeting BTG2
- (2018) Hua Chen et al. Molecular Cancer
- Identification of potential core genes in triple negative breast cancer using bioinformatics analysis
- (2018) Man-Xiu Li et al. OncoTargets and Therapy
- Molecular pathogenesis of triple-negative breast cancer based on microRNA expression signatures: antitumor miR-204-5p targets AP1S3
- (2018) Hiroko Toda et al. JOURNAL OF HUMAN GENETICS
- The promising role of miR-296 in human cancer
- (2018) Lingling Zhu et al. PATHOLOGY RESEARCH AND PRACTICE
- Aberrant miRNAs expressed in HER-2 negative breast cancers patient
- (2018) Cornelia Braicu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- DEPDC1, negatively regulated by miR-26b, facilitates cell proliferation via the up-regulation of FOXM1 expression in TNBC
- (2018) Lei Zhang et al. CANCER LETTERS
- A meta-analysis of biomarkers for the prognosis of triple-negative breast cancer patients
- (2016) Yu Gui et al. Biomarkers in Medicine
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started